Yeaman Kevin J

President and CEO, DirectorDolby Laboratories, Inc. (DLB) · full profile →Form 4 · filed Dec 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.2M
Net Open-Market Flow
-$2.2M
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Sell(S)7K$67.24$449K98K
Dec 17, 2025Sell(S)80$67.54$5K98K
Dec 16, 2025Sell(S)5K$67.16$335K105K
Dec 16, 2025Tax withholding(F)7K$66.62$457K144K
Dec 16, 2025Sell(S)22K$66.64$1.5M110K
Dec 15, 2025Grant(A)66K$0194K
Dec 15, 2025Option exercise(M)18K$0203K
Dec 15, 2025Tax withholding(F)27K$67.54$1.8M157K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)18K$00
Dec 15, 2025Grant(A)145K$0145K
Dec 15, 2025Grant(A)33K$033K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-323431) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about DLB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-25-323431"
Ask your agent
Use Arkolith to summarize insider buying and selling at Dolby Laboratories, Inc.
over the last 90 days and cite the filings.